MedPath

Obecure Ltd.

🇮🇱Israel
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

7

Active:1
Completed:4

Trial Phases

2 Phases

Phase 1:2
Phase 2:4

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials

Phase 2
4 (66.7%)
Phase 1
2 (33.3%)

Evaluation of Co-Administration of Betahistine as Adjunctive to Olanzapine in Healthy Subjects

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2010-07-23
Last Posted Date
2010-12-30
Lead Sponsor
OBEcure Ltd.
Target Recruit Count
90
Registration Number
NCT01168336
Locations
🇷🇴

Pierrel Research HP-RO, Timisoara, Romania

Evaluation of Safety, Drug-Drug Interactions and Pharmacokinetic Profiles of Co-Administration of Betahistine With Olanzapine in Healthy Female Subjects

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2009-02-27
Last Posted Date
2009-05-05
Lead Sponsor
OBEcure Ltd.
Target Recruit Count
50
Registration Number
NCT00852956
Locations
🇷🇴

IFE Human Pharmacology, Timisoara, Romania

Efficacy Study of Betahistine on Body Weight in Obese Female Subjects

Phase 2
Completed
Conditions
Obesity
Interventions
First Posted Date
2008-09-08
Last Posted Date
2009-05-07
Lead Sponsor
OBEcure Ltd.
Target Recruit Count
187
Registration Number
NCT00748436
Locations
🇧🇪

GP: Dr. Van Mulders, Aalst, Belgium

🇧🇪

UZ Antwerpen, Edegem, Belgium

🇧🇪

UZ Gent, Gent, Belgium

and more 8 locations

A Randomized, Double-Blind, Placebo-Controlled Study to Examine the Effect of Betahistine on Plasma Lipids in Patients Treated With Simvastatin

Phase 2
Terminated
Conditions
Hypercholesterolemia
First Posted Date
2007-04-27
Last Posted Date
2007-09-26
Lead Sponsor
OBEcure Ltd.
Target Recruit Count
30
Registration Number
NCT00466869
Locations
🇮🇱

Internal Medicine Department A-Wolfson Medical Center, Holon, Israel

🇮🇱

Internal Medicine Department A-Meir Medical Center, Kfar Saba, Israel

Study to Examine the Effect of Betahistine on Body Weight Gain Due to Olanzapine Treatment

Phase 2
Terminated
Conditions
Weight Gain
Interventions
First Posted Date
2007-01-29
Last Posted Date
2015-10-15
Lead Sponsor
OBEcure Ltd.
Target Recruit Count
36
Registration Number
NCT00428168
Locations
🇨🇦

Capital Health, Edmonton Mental Health Clinic, Edmonton, Alberta, Canada

🇨🇦

Dr. Alexander McIntyre, Penticton, British Columbia, Canada

🇨🇦

Vancouver Island Health Authority, Victoria, British Columbia, Canada

and more 7 locations
  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.